Friday - July 17, 2026
DNA Blood Test Improves Patient Selection for Radiopharmaceutical Therapy in Prostate Cancer
July 16, 2026
RESTON, Virginia, July 16 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:

* * *

DNA Blood Test Improves Patient Selection for Radiopharmaceutical Therapy in Prostate Cancer

*

Media Contact:

Rebecca Maxey

(703) 652-6772

rmaxey@snmmi.org

Reston, VA (July 16, 2026)- A noninvasive DNA blood test can identify metastatic castration- . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products